Background Several studies have shown a relationship between psoriasis and metabolic
syndrome (MS), but no meta-analysis has been restricted to studies that adjusted for …

Many remarkable advances have improved our understanding of the cellular and molecular
events in the pathogenesis of atherosclerosis. Chief among these is the accumulating …

Background Secukinumab, a fully human anti–interleukin-17A monoclonal antibody, has
demonstrated efficacy and safety in patients with moderate to severe plaque psoriasis …

Background Long‐term safety evaluations of biologics are needed to inform patient
management decisions. Objectives To evaluate the safety of ustekinumab in patients with …

Background Ongoing evaluation of biological agents in patients with moderate‐to‐severe
psoriasis is needed to support their long‐term use. Objective To evaluate long‐term efficacy …

Background Psoriasis and atopic dermatitis (AD) are immuno-inflammatory diseases that
can result in lifelong systemic inflammation. Unlike AD, psoriasis has been associated with …

Importance Psoriasis is associated with an increased risk of cardiovascular diseases.
Subclinical atherosclerosis in patients with psoriasis has not been compared with other …

Objectives (i) To estimate the prevalence and severity of coronary artery disease and (ii) to
assess the risk of cardiovascular events and mortality, in patients with psoriasis and psoriatic …

Patients with psoriasis may have an increased risk of cardiovascular disease and
myocardial infarction. The aim of this study was to investigate whether psoriasis is …

Background Studies of children's blood lipid profiles in relation to asthma are few, and the
results are ambiguous. Objective We sought to examine whether the lipid profile is …